• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.

ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS One. 2016; 11(1):e0147344.

View in: PubMed

subject areas
  • Antineoplastic Agents
  • Blotting, Western
  • Carcinoma, Non-Small-Cell Lung
  • Cell Proliferation
  • Drug Resistance, Neoplasm
  • Epithelial-Mesenchymal Transition
  • ErbB Receptors
  • Homeodomain Proteins
  • Humans
  • Immunoenzyme Techniques
  • Lung Neoplasms
  • Mutation
  • Protein Kinase Inhibitors
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • RNA, Messenger
  • RNA, Small Interfering
  • Transcription Factors
  • Tumor Cells, Cultured
  • Zinc Finger E-box-Binding Homeobox 1

authors with profiles
  • Robert M. Gemmill
  • Patrick Nasarre